These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26220132)

  • 21. ALK, lung cancer, and personalized therapy: portent of the future?
    Garber K
    J Natl Cancer Inst; 2010 May; 102(10):672-5. PubMed ID: 20460631
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of the MRP1/ABCC1 multidrug transporter protein in cancer.
    Munoz M; Henderson M; Haber M; Norris M
    IUBMB Life; 2007 Dec; 59(12):752-7. PubMed ID: 18085475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of chemotherapy resistance genes in outcome of neuroblastoma.
    de Cremoux P; Jourdan-Da-Silva N; Couturier J; Tran-Perennou C; Schleiermacher G; Fehlbaum P; Doz F; Mosseri V; Delattre O; Klijanienko J; Vielh P; Michon J
    Pediatr Blood Cancer; 2007 Mar; 48(3):311-7. PubMed ID: 16609945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trial inclusion in patients with relapsed/refractory neuroblastoma following the European Precision Cancer Medicine trial MAPPYACTS.
    Chaix J; Schleiermacher G; Corradini N; André N; Thebaud E; Gambart M; Defachelles AS; Entz-Werle N; Chastagner P; De Carli É; Ducassou S; Landman-Parker J; Adam-de-Beaumais T; Larive A; Michiels S; Vassal G; Valteau-Couanet D; Geoerger B; Berlanga P
    Eur J Cancer; 2024 Apr; 201():113923. PubMed ID: 38377775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest.
    Yaari S; Jacob-Hirsch J; Amariglio N; Haklai R; Rechavi G; Kloog Y
    Clin Cancer Res; 2005 Jun; 11(12):4321-30. PubMed ID: 15958613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of new ALK mutations at relapse of neuroblastoma.
    Schleiermacher G; Javanmardi N; Bernard V; Leroy Q; Cappo J; Rio Frio T; Pierron G; Lapouble E; Combaret V; Speleman F; de Wilde B; Djos A; Ora I; Hedborg F; Träger C; Holmqvist BM; Abrahamsson J; Peuchmaur M; Michon J; Janoueix-Lerosey I; Kogner P; Delattre O; Martinsson T
    J Clin Oncol; 2014 Sep; 32(25):2727-34. PubMed ID: 25071110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Micro-RNA-21 regulates the sensitivity to cisplatin in human neuroblastoma cells.
    Chen Y; Tsai YH; Fang Y; Tseng SH
    J Pediatr Surg; 2012 Oct; 47(10):1797-805. PubMed ID: 23084187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The coamplification pattern of the MYCN amplicon is an invariable attribute of most MYCN-amplified human neuroblastomas.
    Weber A; Starke S; Bergmann E; Christiansen H
    Clin Cancer Res; 2006 Dec; 12(24):7316-21. PubMed ID: 17189403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
    Spitz R; Hero B; Simon T; Berthold F
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3368-73. PubMed ID: 16740759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of metastatic recurrent neuroblastoma to nitisinone: a modulator of tyrosine metabolism.
    Kobrinsky NL; Sjolander DE
    Pediatr Blood Cancer; 2006 Apr; 46(4):517-20. PubMed ID: 15940725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of In Vivo Acquired Resistance to Chemotherapy Via Individual Dose Escalation Treatment Regime.
    Barker KT; Yogev O
    Methods Mol Biol; 2022; 2535():73-83. PubMed ID: 35867223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activating FGFR2-RAS-BRAF mutations in ameloblastoma.
    Brown NA; Rolland D; McHugh JB; Weigelin HC; Zhao L; Lim MS; Elenitoba-Johnson KS; Betz BL
    Clin Cancer Res; 2014 Nov; 20(21):5517-26. PubMed ID: 24993163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HaRas activates the NADPH oxidase complex in human neuroblastoma cells via extracellular signal-regulated kinase 1/2 pathway.
    Serù R; Mondola P; Damiano S; Svegliati S; Agnese S; Avvedimento EV; Santillo M
    J Neurochem; 2004 Nov; 91(3):613-22. PubMed ID: 15485492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase 10-promoted autophagy as a druggable point of interference to improve the treatment response of advanced neuroblastomas.
    Oehme I; Lodrini M; Brady NR; Witt O
    Autophagy; 2013 Dec; 9(12):2163-5. PubMed ID: 24145760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aiming at neuroblastoma and hitting other worthy targets.
    Schor NF
    J Child Neurol; 2013 Jun; 28(6):768-73. PubMed ID: 23576410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knowledge of genomic testing among early-stage breast cancer patients.
    Richman AR; Tzeng JP; Carey LA; Retèl VP; Brewer NT
    Psychooncology; 2011 Jan; 20(1):28-35. PubMed ID: 20200857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful second autologous peripheral blood stem cell transplantation conditioned with total body irradiation for progressive neuroblastoma after recurrence.
    Morimoto T; Matsufuji H; Yokomori K; Hosoya R
    Tokai J Exp Clin Med; 2006 Dec; 31(4):154-6. PubMed ID: 21302246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the right treatments for neuroblastoma.
    Nelson NJ
    J Natl Cancer Inst; 2011 Aug; 103(16):1218-21. PubMed ID: 21813407
    [No Abstract]   [Full Text] [Related]  

  • 40. Targeting ALK: The Ten Lives of a Tumor.
    Versteeg R; George RE
    Cancer Discov; 2016 Jan; 6(1):20-1. PubMed ID: 26747894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.